{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:14:04Z","timestamp":1782562444044,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3177,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/modpathol.2013.197","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T08:55:03Z","timestamp":1383296103000},"page":"740-750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions"],"prefix":"10.1016","volume":"27","author":[{"given":"Daphne","family":"C Ang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L","family":"Warrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Shilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Beadling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L","family":"Corless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L","family":"Troxell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2013.197_bib1","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1158\/1078-0432.CCR-07-0266","article-title":"Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas","volume":"13","author":"Barbareschi","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.197_bib2","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","article-title":"An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer","volume":"68","author":"Stemke-Hale","year":"2008","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.197_bib3","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1158\/1078-0432.CCR-09-0632","article-title":"PIK3CA mutation associates with improved outcome in breast cancer","volume":"15","author":"Kalinsky","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.197_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature11143","article-title":"Whole-genome analysis informs breast cancer response to aromatase inhibition","volume":"486","author":"Ellis","year":"2012","journal-title":"Nature"},{"key":"10.1038\/modpathol.2013.197_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature11154","article-title":"Sequence analysis of mutations and translocations across breast cancer subtypes","volume":"486","author":"Banerji","year":"2012","journal-title":"Nature"},{"key":"10.1038\/modpathol.2013.197_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"key":"10.1038\/modpathol.2013.197_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"10.1038\/modpathol.2013.197_bib8","first-page":"002","article-title":"PIK3CA\/AKT1 mutations in breast carcinoma: A comprehensive review of experimental and clinical studies","volume":"S1","author":"Troxell","year":"2012","journal-title":"J Clin Exper Pathol"},{"issue":"Suppl 3","key":"10.1038\/modpathol.2013.197_bib9","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.3816\/CBC.2010.s.013","article-title":"Deciphering the role of PI3K\/Akt\/mTOR pathway in breast cancer biology and pathogenesis","volume":"10","author":"McAuliffe","year":"2010","journal-title":"Clin Breast Cancer"},{"key":"10.1038\/modpathol.2013.197_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ctrv.2012.11.002","article-title":"Defining biomarkers to predict sensitivity to PI3K\/Akt\/mTOR pathway inhibitors in breast cancer","volume":"39","author":"Gonzalez-Angulo","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1038\/modpathol.2013.197_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"key":"10.1038\/modpathol.2013.197_bib12","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1073\/pnas.0907011107","article-title":"PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer","volume":"107","author":"Loi","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2013.197_bib13","doi-asserted-by":"crossref","first-page":"e15647","DOI":"10.1371\/journal.pone.0015647","article-title":"Gene expression profiling reveals new aspects of PIK3CA mutation in Eralpha-positive breast cancer: major implication of the Wnt signaling pathway","volume":"5","author":"Cizkova","year":"2010","journal-title":"PloS One"},{"key":"10.1038\/modpathol.2013.197_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10549-009-0406-1","article-title":"Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma","volume":"120","author":"Dunlap","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2013.197_bib15","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1158\/0008-5472.CAN-08-2660","article-title":"PIK3CA mutations in in situ and invasive breast carcinomas","volume":"70","author":"Miron","year":"2010","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.197_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yexmp.2009.09.016","article-title":"PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast","volume":"88","author":"Li","year":"2010","journal-title":"Exp Mol Pathol"},{"key":"10.1038\/modpathol.2013.197_bib17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-011-1601-4","article-title":"PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression","volume":"129","author":"Kalinsky","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2013.197_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/modpathol.2009.142","article-title":"High prevalence of PIK3CA\/AKT pathway mutations in papillary neoplasms of the breast","volume":"23","author":"Troxell","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.197_bib19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/modpathol.2012.55","article-title":"Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions","volume":"25","author":"Troxell","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.197_bib20","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.humpath.2012.03.012","article-title":"Mucinous breast carcinomas lack PIK3CA and AKT1 mutations","volume":"43","author":"Kehr","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.197_bib21","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.humpath.2012.10.018","article-title":"Troxell ML. PIK3CA-AKT pathway mutations in micropapillary breast carcinoma","volume":"44","author":"Flatley","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.197_bib22","unstructured":"Wolters KL, Ang D, Warrick A et al. Frequent PIK3CA mutations in radial scars. Diagn Mol Pathol (in press)."},{"key":"10.1038\/modpathol.2013.197_bib23","doi-asserted-by":"crossref","unstructured":"Newburger DE, Kashef-Haghighi D, Weng Z et al. Genome evolution during progression to breast cancer. Genome Res. 2013;23:1097\u20131108.","DOI":"10.1101\/gr.151670.112"},{"key":"10.1038\/modpathol.2013.197_bib24","series-title":"WHO Classification of Tumours of the Breast","first-page":"84","article-title":"Intraductal proliferative lesions","author":"Schnitt","year":"2012"},{"key":"10.1038\/modpathol.2013.197_bib25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00000478-199212000-00001","article-title":"Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria","volume":"16","author":"Schnitt","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.197_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00125480-200305000-00001","article-title":"Columnar cell lesions of the breast","volume":"10","author":"Schnitt","year":"2003","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2013.197_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jmoldx.2011.04.003","article-title":"Multiplex mutation screening by mass spectrometry: evaluation of 820 cases from a personalized cancer medicine registry","volume":"13","author":"Beadling","year":"2011","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2013.197_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jmoldx.2012.12.005","article-title":"Novel method for PIK3CA mutation analysis: locked nucleic acid-PCR sequencing","volume":"15","author":"Ang","year":"2013","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2013.197_bib29","first-page":"129","article-title":"Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations","volume":"74","author":"Lakhani","year":"1996","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.2013.197_bib30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jnci\/90.9.697","article-title":"Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci","volume":"90","author":"O'Connell","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2013.197_bib31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<272::AID-PATH265>3.0.CO;2-2","article-title":"The transition from hyperplasia to invasive carcinoma of the breast","volume":"187","author":"Lakhani","year":"1999","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2013.197_bib32","first-page":"2410","article-title":"Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization","volume":"7","author":"Gong","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.197_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.1280","article-title":"Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast","volume":"199","author":"Jones","year":"2003","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2013.197_bib34","first-page":"1469","article-title":"Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor","volume":"19","author":"Xu","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1038\/modpathol.2013.197_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/bcr650","article-title":"The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions","volume":"5","author":"Reis-Filho","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1038\/modpathol.2013.197_bib36","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/01.pas.0000157295.93914.3b","article-title":"Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis","volume":"29","author":"Simpson","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.197_bib37","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.1995.13.9.2293","article-title":"p53 mutations in benign breast tissue","volume":"13","author":"Millikan","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.197_bib38","first-page":"785","article-title":"p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias","volume":"58","author":"Done","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.197_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/1097-0215(20000701)87:1<73::AID-IJC11>3.0.CO;2-U","article-title":"p53 protein accumulation and mutations in normal and benign breast tissue","volume":"87","author":"Kandel","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2013.197_bib40","first-page":"929","article-title":"Genetic mutations and expression of p53 in non-invasive breast lesions","volume":"3","author":"Mao","year":"2010","journal-title":"Mol Med Rep"},{"key":"10.1038\/modpathol.2013.197_bib41","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00432-010-0781-3","article-title":"PTEN mutation spectrum in breast cancers and breast hyperplasia","volume":"136","author":"Yang","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1038\/modpathol.2013.197_bib42","first-page":"4026","article-title":"A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions","volume":"60","author":"Fuqua","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.197_bib43","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1158\/0008-5472.CAN-08-4194","article-title":"Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K\/Akt kinase pathway","volume":"69","author":"Barone","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.197_bib44","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","article-title":"The life history of 21 breast cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"key":"10.1038\/modpathol.2013.197_bib45","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nm.2402","article-title":"Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms","volume":"17","author":"Liu","year":"2011","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2013.197_bib46","doi-asserted-by":"crossref","first-page":"e36924","DOI":"10.1371\/journal.pone.0036924","article-title":"Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERalpha-positive tumors","volume":"7","author":"Tikoo","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/modpathol.2013.197_bib47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/onc.2012.53","article-title":"Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations","volume":"32","author":"Yuan","year":"2013","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2013.197_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/path.2207","article-title":"FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer","volume":"213","author":"Tomlinson","year":"2007","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2013.197_bib49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00345-007-0213-4","article-title":"Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target","volume":"25","author":"Knowles","year":"2007","journal-title":"World J Urol"},{"key":"10.1038\/modpathol.2013.197_bib50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF02967628","article-title":"Estrogen receptor alpha mutation (A-to-G transition at nucleotide 908) is not found in different types of breast lesions from Japanese women","volume":"10","author":"Zhang","year":"2003","journal-title":"Breast Cancer"},{"key":"10.1038\/modpathol.2013.197_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/gcc.20017","article-title":"Estrogen receptor alpha (ESR1) mutant A908G is not a common feature in benign and malignant proliferations of the breast","volume":"40","author":"Tebbit","year":"2004","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2013197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2013197","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222035888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222035888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2013197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:12:55Z","timestamp":1760231575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222035888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0893395222035888"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2013.197","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2013.197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}